CPF impedes cell cycle re-entry of quiescent lung cancer cells through transcriptional suppression of FACT and c-MYC.
Ling BiChanlu XieLijing JiaoShenyi JinSu Su Thae HnitYao MuYilun WangQian WangGuangbo GeYaqiao WangXiao-Dong ZhaoXinglong ShiYani KangPaul De SouzaTao LiuJia ZhouLing XuQihan DongPublished in: Journal of cellular and molecular medicine (2020)
Blockade of cell cycle re-entry in quiescent cancer cells is a strategy to prevent cancer progression and recurrence. We investigated the action and mode of action of CPF mixture (Coptis chinensis, Pinellia ternata and Fructus trichosanthis) in impeding a proliferative switch in quiescent lung cancer cells. The results indicated that CPF impeded cell cycle re-entry in quiescent lung cancer cells by reduction of FACT and c-MYC mRNA and protein levels, with concomitant decrease in H3K4 tri-methylation and RNA polymerase II occupancy at FACT and c-MYC promoter regions. Animals implanted with quiescent cancer cells that had been exposed to CPF had reduced tumour volume/weight. Thus, CPF suppresses proliferative switching through transcriptional suppression of FACT and the c-MYC, providing a new insight into therapeutic target and intervention method in impeding cancer recurrence.
Keyphrases
- cell cycle
- genome editing
- crispr cas
- cell proliferation
- papillary thyroid
- neural stem cells
- gene expression
- transcription factor
- dna methylation
- squamous cell
- randomized controlled trial
- squamous cell carcinoma
- lymph node metastasis
- binding protein
- free survival
- weight gain
- childhood cancer
- oxidative stress
- amino acid
- heat shock
- young adults
- high speed
- single molecule